HCPCS Codes Similar to P3

HCPCS Codes Similar to “P3” Code.
A patient with severe systemic disease

P4 A patient with severe systemic disease that is a constant threat to life Code added date: 20060101 Code effective date: 20060101 TXT \| PDF \| XML \| JSON	C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source Code added date: 20200301 Code effective date: 20240101 TXT \| PDF \| XML \| JSON
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source Code added date: 20200301 Code effective date: 20230512 TXT \| PDF \| XML \| JSON	G2024 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source Code added date: 20200301 Code effective date: 20230512 TXT \| PDF \| XML \| JSON
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r Code added date: 20200414 Code effective date: 20230512 TXT \| PDF \| XML \| JSON	U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 Code added date: 20210101 Code effective date: 20230512 TXT \| PDF \| XML \| JSON
G9128 Oncology; disease status; limited to multiple myeloma, systemic disease; smoldering, stage i (for use in a medicare-approved demonstration project) Code added date: 20060101 Code effective date: 20070101 TXT \| PDF \| XML \| JSON	G9129 Oncology; disease status; limited to multiple myeloma, systemic disease; stage ii or higher (for use in a medicare-approved demonstration project) Code added date: 20060101 Code effective date: 20070101 TXT \| PDF \| XML \| JSON
G9130 Oncology; disease status; limited to multiple myeloma, systemic disease; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project) Code added date: 20060101 Code effective date: 20070101 TXT \| PDF \| XML \| JSON	G9765 Documentation that the patient declined change in medication or alternative therapies were unavailable, has documented contraindications, or has not been treated with a systemic medication for at least six consecutive months (e.g., experienced adverse effects or lack of efficacy with all other therapy options) in order to achieve better disease control as measured by pga, bsa, pasi, or dlqi Code added date: 20170101 Code effective date: 20190101 TXT \| PDF \| XML \| JSON
P2 A patient with mild systemic disease Code added date: 20060101 Code effective date: 20060101 TXT \| PDF \| XML \| JSON	G0037 On date of encounter, patient is not able to participate in assessment or screening, including non-verbal patients, delirious, severely aphasic, severely developmentally delayed, severe visual or hearing impairment and for those patients, no knowledgeable informant available Code added date: 20220101 Code effective date: 20220101 TXT \| PDF \| XML \| JSON
G9 Monitored anesthesia care for patient who has history of severe cardio-pulmonary condition Code added date: 19990701 Code effective date: 19990701 TXT \| PDF \| XML \| JSON	G9536 Documentation of medical reason(s) for ordering an advanced brain imaging study (i.e., patient has an abnormal neurological examination; patient has the coexistence of seizures, or both; recent onset of severe headache; change in the type of headache; signs of increased intracranial pressure (e.g., papilledema, absent venous pulsations on funduscopic examination, altered mental status, focal neurologic deficits, signs of meningeal irritation); hiv-positive patients with a new type of headache; immunocompromised patient with unexplained headache symptoms; patient on coagulopathy/anti-coagulation or anti-platelet therapy; very young patients with unexplained headache symptoms) Code added date: 20160101 Code effective date: 20190101 TXT \| PDF \| XML \| JSON